About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  HISTORICAL VOLUME
Historical Volume      
Ajanta Pharma Ltd.
BSE Code 532331
ISIN Demat INE031B01049
Book Value 350.00
NSE Code AJANTPHARM
Dividend Yield % 0.98
Market Cap 357628.22
P/E 37.93
EPS 75.48
Face Value 2  
Exchange : Period From : Period To :
DateOpen Price(Rs.)High Price(Rs.)Low Price(Rs.)Close Price(Rs.)VolumeTurnover
24-Mar-2026 2854.20 2877.45 2778.35 2862.50 4048 11444323
23-Mar-2026 2856.05 2893.40 2787.60 2800.40 5455 15405709
20-Mar-2026 2946.90 2999.00 2872.85 2904.20 5209 15124292
19-Mar-2026 3000.60 3056.15 2935.00 2946.15 1894 5644573
18-Mar-2026 3021.00 3114.25 3021.00 3055.70 3711 11367506
17-Mar-2026 2955.05 3067.60 2955.05 3020.95 3870 11728309
16-Mar-2026 3000.95 3030.60 2931.00 2952.10 4742 14042679
13-Mar-2026 3139.40 3158.20 3005.35 3028.90 8614 26216683
12-Mar-2026 2980.05 3148.60 2970.00 3122.15 12919 40168489
11-Mar-2026 3024.60 3085.00 3016.60 3045.35 6138 18787926
10-Mar-2026 2934.60 3025.00 2934.60 3000.05 91087 273264854
09-Mar-2026 2982.50 2982.50 2856.60 2933.75 134312 396586716
06-Mar-2026 2970.00 3031.00 2970.00 2990.90 2357 7077344
05-Mar-2026 2900.65 2989.00 2900.60 2974.50 3210 9483227
04-Mar-2026 2964.05 2964.05 2875.55 2916.25 2205 6411866
02-Mar-2026 2761.05 2975.00 2761.05 2964.70 4583 13426949
Page 1 of 1
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.